The Staphylococcus aureus bacterium is one of the common pathogens and can cause sepsis. The new antibiotic dalbavancin is very effective against many bacterial pathogens. However, resistance to the antibiotic was seen to develop during the treatment of a patient with an implanted cardiac device.
A team of researchers led by infectiologists from the Division of Infectious Diseases and Tropical Medicine, Manuel Kussmann and Heimo Lagler, have now described the phenotypical and genotypical mechanism of this development of resistance for the first time. The study was published in " Emerging Microbes & Infections ".